Dr. Peter Fitzgerald

 

Dr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School. He is an Interventional Cardiologist and has a PhD in Engineering.

 

He is Professor in both the Departments of Medicine and Engineering at Stanford.  Presently, Dr. Fitzgerald’s laboratory includes 17 postdoctoral fellows and graduate engineering students focusing on state-of-the-art technologies in Cardiovascular Medicine. 

 

He has led or participated in over 150 clinical trials, published over 450 manuscripts/chapters, and lectures worldwide.  He has trained over 150 post-docs in Engineering and Medicine in the past decade.  In addition, he heads the Stanford/Asia MedTech innovation program

 

Peter has been principle/founder of eighteen medical device companies in the San Francisco Bay Area. He has transitioned twelve of these start-ups to large medical device companies.

 

He serves on several boards of directors, advised dozens of medical device startups as well as multinational healthcare companies in the design and development of new diagnostic and therapeutic devices in the cardiovascular arena.

 

In 2001, Peter was on the founding team of LVP Capital, a venture firm that has raised three funds focused on medical device and biotechnology start-ups in San Francisco. In 2009, he co-founded Triventures and dedicates a significant portion of his time working closely with the companies and comes to Israel once a month.